Analysis Ocugen’s CFO Buys In as the Pipeline Enters a Defining Stretch
Shares of Ocugen have shed more than half their value since hitting a 52-week high of €2.35 in March, but the company’s chief financial officer has just put her own...
Top Stories
Latest financial market updates and expert analysis
Analysis 
AI & Quantum Computing
View All
Defense & Aerospace
View All
Cryptocurrency
View All
Banking & Finance
View All
Latest News
Analysis
Plug Power’s June 30 Ultimatum Meets a 2027 Policy Cliff: How Asset Sales Are Buying Time
The calendar is closing in on Plug Power from two directions. By the end of this week, the hydrogen company...
Commodities
Bougainville Copper Loses Panguna as State-Backed Miner Takes Over in Pre-Independence Shift
The Autonomous Bougainville Government has revoked the Panguna exploration licence held by Bougainville Copper, the company in which it holds...
Analysis
Outlook Therapeutics: A 479% Surge Sets the Stage for a July of High Stakes
Outlook Therapeutics has stormed back from the brink. The stock closed Friday at $1.58, marking a roughly 479% gain over...
Analysis
Take-Two’s GTA VI Hype Hits Fever Pitch as Insider Sales Top $134 Million and Technical Indicators Flash Overbought
Investor excitement over Grand Theft Auto VI is pushing Take-Two Interactive stock to new heights, but a closer look under...
Analysis
BYD Shares Hover Near 52-Week Low as Record Charging Tech Can’t Offset Sales Slump and Margin Squeeze
BYD can now charge a 130-kWh battery from 10% to 97% in nine minutes, but no amount of supercharging speed...
Commodities
Gold’s Three-Week Rout Defies Central Bank Buying Spree as Fed Hawks Tighten the Screws
The precious metal finds itself trapped between two powerful and opposing forces. Central banks hoarded 244 tonnes of gold in...
Dividends
Inflation Data Looms Large for VanEck Dividend ETF After Fed Pulls a Hawkish Pivot
Thursday’s release of May’s Personal Consumption Expenditures (PCE) price index will be a decisive moment for the VanEck Morningstar Developed...
Analysis
Novo Nordisk’s Pill Boom Hits 3 Million Scripts as a €69 Million Research Blitz Backs the Next Frontier
More than three million Wegovy pill prescriptions have been written in the United States in just five months — a...
Asian Markets
Japan’s Tungsten Hexafluoride Pullout and South Korea’s Molybdenum Squeeze Put Almonty in the Spotlight
Two Japanese chemical manufacturers, Kanto Denka and Central Glass, have announced they will halt production of tungsten hexafluoride (WF₆) by...
Analysis
Goldman Warns of 50% Profit Shrinkage at Xiaomi as Stock Buyback and Skynomad SUV Fail to Inspire
A perfect storm of surging memory costs, a stalling EV business, and a broader market downturn is bearing down on...